Wednesday, October 16, 2019

Glenmark Pharma gets USFDA nod for prostate cancer treatment drug

Glenmark Pharma gets USFDA nod for prostate cancer treatment drug "Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food Drug Administration (USFDA) for Abiraterone Acetate tablets USP, 250 mg," the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2VNMQIP

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...